Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...

Study will evaluate clofutriben for the treatment of Autonomous Cortisol Secretion Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies ...